博瑞医药决定不提前赎回“博瑞转债”，未来三月亦暂不行使

Core Viewpoint - 博瑞生物医药（苏州）股份有限公司 has triggered conditional redemption terms for its convertible bonds due to stock price performance, but has decided not to exercise the early redemption option to protect investor interests [1] Group 1: Redemption Conditions - The company’s stock has met the condition of closing prices being at least 130% of the conversion price (45.16 CNY/share) for 15 out of 30 consecutive trading days from August 22 to September 11, 2025 [1] - The board of directors approved the decision not to redeem the "博瑞转债" early on September 11 [1] Group 2: Future Considerations - The company will not exercise the early redemption right for the next three months (from September 12 to December 11) even if the redemption conditions are met again [1] - No trading of "博瑞转债" has occurred by relevant parties within the six months prior to the satisfaction of the redemption conditions [1]